| Breakdown | TTM | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 106.10B | 109.71B | 106.14B | 100.88B | 95.58B | 88.28B |
| Gross Profit | 32.10B | 32.70B | 32.02B | 30.59B | 26.93B | 26.70B |
| EBITDA | 12.55B | 12.84B | 13.01B | 12.63B | 10.47B | 10.91B |
| Net Income | 8.64B | 12.25B | 10.73B | 11.82B | 9.03B | 8.83B |
Balance Sheet | ||||||
| Total Assets | 189.35B | 205.26B | 191.11B | 183.08B | 169.04B | 157.47B |
| Cash, Cash Equivalents and Short-Term Investments | 105.18B | 105.24B | 108.79B | 105.89B | 99.50B | 110.39B |
| Total Debt | 3.00B | 3.00B | 3.00B | 3.00B | 3.00B | 3.11B |
| Total Liabilities | 26.55B | 30.50B | 27.58B | 30.46B | 28.07B | 25.82B |
| Stockholders Equity | 162.80B | 174.76B | 163.52B | 152.61B | 140.97B | 131.64B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 9.20B | 6.90B | 8.51B | 6.92B | 7.64B |
| Operating Cash Flow | 0.00 | 12.76B | 8.28B | 9.18B | 7.15B | 7.74B |
| Investing Cash Flow | 0.00 | -18.73B | -12.12B | -9.56B | -20.55B | -9.92B |
| Financing Cash Flow | 0.00 | -1.74B | -2.00B | -1.23B | -1.34B | -1.09B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥111.87B | 8.38 | ― | 3.72% | 4.49% | 27.96% | |
73 Outperform | ¥150.83B | 11.18 | 6.23% | 1.11% | 3.36% | 14.17% | |
69 Neutral | ¥2.44T | 11.00 | 11.64% | 1.52% | 11.97% | 45.59% | |
64 Neutral | ¥421.88B | 4.51 | 8.14% | 2.61% | -0.45% | 50.53% | |
63 Neutral | ¥389.67B | 13.04 | 13.71% | 3.38% | 0.16% | -12.55% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
52 Neutral | ¥34.62B | 20.68 | ― | 3.70% | 29.30% | -82.16% |